Chemed’s (NYSE:CHE) Q2 Earnings Results: Revenue In Line With Expectations But Stock DropsHealthcare services company Chemed Corporation (
NYSE:CHE) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $618.8 million. Its non-GAAP profit of $4.27 per share was 14.3% below analysts’ consensus estimates.
Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure
Chemed Corporation (Chemed) (
NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2025, versus the comparable prior-year period.
Chemed (CHE) Q2 Earnings: What To ExpectHealthcare services company Chemed Corporation (
NYSE:CHE)
will be reporting results this Tuesday after market hours. Here’s what to expect.
1 Oversold Stock Primed to Rebound and 2 to IgnoreThe past year hasn't been kind to the stocks featured in this article.
Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
3 Profitable Stocks with Open QuestionsWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Why Chemed (CHE) Shares Are Plunging TodayShares of healthcare services company Chemed Corporation (
NYSE:CHE)
fell 14.7% in the afternoon session after the company provided a negative update on its full-year 2025 guidance, citing issues with its VITAS hospice business.
Chemed To Report Second-Quarter 2025 Earnings July 29, 2025
Chemed Corporation (
NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange.
1 Cash-Producing Stock Worth Your Attention and 2 to Brush OffGenerating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Senior Health, Home Health & Hospice Stocks Q1 In Review: Chemed (NYSE:CHE) Vs PeersAs the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including Chemed (
NYSE:CHE) and its peers.
3 Healthcare Stocks Skating on Thin IceFrom novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 12.3%. This performance was noticeably worse than the S&P 500’s 1.9% fall.
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Stockholders of Chemed Corporation (
NYSE: CHE) today elected a slate of nine directors at the Company’s 2025 annual stockholders’ meeting.
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
Chemed Corporation (
NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City.
